Deliberate AI Announces its Depression and Anxiety Model, AI-COA™, is the First AI/ML Initiative to Be Accepted into the FDA’s ISTAND Pilot Program to Advance Drug Development
Digital Health Global
JANUARY 26, 2024
NEW YORK–(BUSINESS WIRE)– Deliberate AI , a digital health technology company that delivers precision measurement of mental health through AI, today announced its inclusion in the U.S. This enables more precise triage and replaces patient surveys with passive background monitoring for enhanced measurement-based care.
Let's personalize your content